| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 27.675 | 35.570 | 31.280 | 56.163 | 35.289 | 49.299 |
| Total Income - EUR | - | - | - | - | 27.831 | 35.570 | 31.390 | 57.338 | 46.270 | 49.319 |
| Total Expenses - EUR | - | - | - | - | 9.310 | 10.936 | 16.090 | 58.100 | 28.383 | 31.067 |
| Gross Profit/Loss - EUR | - | - | - | - | 18.520 | 24.634 | 15.300 | -762 | 17.887 | 18.252 |
| Net Profit/Loss - EUR | - | - | - | - | 17.994 | 23.567 | 14.360 | -2.922 | 17.541 | 17.783 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Biovista Mercando S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 715 |
| Current Assets | - | - | - | - | 21.530 | 52.786 | 66.354 | 65.178 | 52.548 | 42.522 |
| Inventories | - | - | - | - | 3.941 | 6.222 | 5.566 | 22.619 | 19.527 | 18.801 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 44.940 | 24.263 | 17.031 |
| Cash | - | - | - | - | 17.589 | 46.563 | 60.788 | -2.382 | 8.758 | 6.691 |
| Shareholders Funds | - | - | - | - | 21.191 | 44.356 | 18.089 | 2.305 | 2.255 | 20.025 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 339 | 8.430 | 48.264 | 62.872 | 50.293 | 23.212 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Biovista Mercando S.r.l.